Page last updated: 2024-11-03

probenecid and Remission, Spontaneous

probenecid has been researched along with Remission, Spontaneous in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodwin, FK1
Post, RM1
van Praag, HM1
Korf, J1

Reviews

1 review available for probenecid and Remission, Spontaneous

ArticleYear
Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Research publications - Association for Research in Nervous and Mental Disease, 1975, Volume: 54

    Topics: 3,4-Dihydroxyphenylacetic Acid; Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Depressio

1975

Trials

1 trial available for probenecid and Remission, Spontaneous

ArticleYear
5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    The Journal of nervous and mental disease, 1974, Volume: 158, Issue:5

    Topics: 5-Hydroxytryptophan; Biological Transport; Brain; Brain Chemistry; Clinical Trials as Topic; Depress

1974